Alcohol Research Programs (93.273)
Alcohol Research Programs (Assistance Listing 93.273) is run by the National Institutes of Health, part of the Department of Health and Human Services. It awarded $2.2 billion in 2,255 grants from fiscal 2021 to 2025, about $974,579 per award on average. 92 funding opportunities are open or forecast now.
The typical award was $509,521. Half of the 2,254 awards fell between $208,557 and $1.4 million, and they ranged from $0 to $34.3 million.
- Awarded, FY 2021 to 2025$2.2 billion
- Grant awards2,255
- Typical award$509,521
- Awarded in FY 2025$449 million
- Size rank150 of 1,823
- Type of assistanceProject grants
Key findings
- Annual funding rose from $416 million in fiscal 2021 to $449 million in fiscal 2025.
- It is the 150th largest of 1,823 federal grant programs by five-year awards.
- The 20 largest recipients received 39% of the money.
- Awards went to recipients in 49 states and territories.
What the program funds
To develop a sound fundamental knowledge base which can be applied to the development of improved methods of treatment and more effective strategies for preventing alcoholism and alcohol-related problems. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) supports research in a broad range of disciplines and subject areas related to biomedical and genetic factors, psychological and environmental factors, alcohol-related problems and medical disorders, health services research, and prevention and treatment research. Small Business Innovation Research (SBIR) program: to increase private sector commercialization of innovations derived from Federal research and development; to increase small business participation in Federal research and development; and to foster and encourage participation of socially and economically disadvantaged small business concerns and women-owned small business concerns in technological innovation. Small Business Technology Transfer (STTR) program: To stimulate and foster scientific and technological innovation and technology transfer through cooperative research and development carried out between small business concerns and research institutions; to increase private sector commercialization of innovations derived from Federal research and development; and to foster and encourage participation of socially and economically disadvantaged small business concerns and women-owned small business concerns in technological innovation.
Open and forecast opportunities
- Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
- HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
- Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)
- Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required)
- HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) - Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center (U2C Clinical Trial Not Allowed)
- Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)
- Specialized Alcohol Research Centers (P50 Clinical trial Optional)
- BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)
- BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
- BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed)
- Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)
- Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Required)
- Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed)
- Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required)
- Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)
Rules from the program listing
Who can apply
Public or private profit and nonprofit agencies, including State, local, or regional government agencies, universities, colleges, hospitals, academic or research institutions may apply for research grants. SBIR grants can be awarded only to domestic small businesses (entities that are independently owned and operated for profit, are not dominant in the field in which research is proposed, and have no more than 500 employees). Primary employment (more than one-half time) of the principal investigator must be with the small business at the time of award and during the conduct of the proposed project. In both Phase I and Phase II, the research must be performed in the U.S. and its possessions. To be eligible for funding, a grant application must be approved for scientific merit and program relevance by a scientific review group and a national advisory council. STTR grants can be awarded only to domestic small business concerns (entities that are independently owned and operated for profit, are not dominant in the field in which research is proposed and have no more than 500 employees) which "partner" with a research institution in cooperative research and development. At least 40 percent of the project is to be performed by the small business concern and at least 30 percent by the research institution. In both Phase I and Phase II, the research must be performed in the U.S. and its possessions.
What the money can and cannot pay for
(1) Research Project Grants provide support for clearly defined projects or a small group of related activities, and when appropriate, support of conferences; (2) Program Project Grants are for large-scale, broad-based programs of research, usually interdisciplinary, consisting of several projects with a common focus; (3) Small Grants are for small-scale exploratory and pilot studies or exploration of an unusual research opportunity; Small Grants are limited to $50,000 for direct costs for a period of up to 2 years; (4) Exploratory/Developmental Grants are limited for a period of up to 2 years, and a maximum of $275,000 for direct costs for the entire 2- year period. Funds may be used only for expenses directly related to the approved research project. SBIR Phase I grants (of approximately 6- months' duration) are to establish the technical merit and feasibility of a proposed research effort that may lead to a commercial product or processes. Phase II grants are for the continuation of the research initiated in Phase I, and that are likely to result in commercial products or processes. STTR Phase I grants (normally of 1-year duration) are to determine the scientific, technical, and commercial merit and feasibility of the proposed cooperative effort that has potential for commercial application. Phase II funding is based on results of research initiated in Phase I and scientific and technical merit and commercial potential of Phase II application; (5).
Matching requirements
This program has no statutory formula. Matching requirements are not applicable to this assistance listing. MOE requirements are not applicable to this assistance listing.
Funding history and past recipients
From fiscal 2021 to 2025, Alcohol Research Programs (93.273) awarded $2.2 billion across 2,255 grant awards, an average of $974,579 per award.
Who usually wins
Colleges and universities received 73% of the money, nonprofits 19% and small businesses 3.8%.
| Recipient type | Awards | Amount | Share |
|---|---|---|---|
| Colleges and universities | 1,726 | $1.6 billion | 73% |
| Nonprofits | 337 | $412 million | 19% |
| Other | 105 | $89.8 million | 4.1% |
| Small businesses | 84 | $83.6 million | 3.8% |
| Tribal governments and organizations | 2 | $457,480 | less than 0.1% |
| State and local governments | 1 | $49,707 | 0% |
By state
44 states have a page for this program: those that received at least $1 million or 10 awards.
| State | Awards | Amount |
|---|---|---|
| California | 309 | $342 million |
| New York | 154 | $184 million |
| North Carolina | 150 | $144 million |
| Massachusetts | 106 | $120 million |
| Connecticut | 91 | $98.3 million |
| Texas | 126 | $93.3 million |
| Pennsylvania | 98 | $78.3 million |
| Maryland | 60 | $77.6 million |
| Illinois | 75 | $69.8 million |
| Washington | 82 | $65.4 million |
| Ohio | 52 | $59.6 million |
| Rhode Island | 77 | $58.4 million |
| Virginia | 65 | $57.4 million |
| Indiana | 53 | $57.1 million |
| Michigan | 39 | $56.5 million |
| Florida | 59 | $53.8 million |
| South Carolina | 62 | $52.3 million |
| Kentucky | 42 | $48.6 million |
| New Mexico | 47 | $44.3 million |
| Louisiana | 64 | $40.3 million |
| Tennessee | 46 | $39.8 million |
| Oregon | 34 | $39.5 million |
| Minnesota | 40 | $38.6 million |
| Colorado | 41 | $35.9 million |
| Georgia | 41 | $33.8 million |
| Missouri | 39 | $29.2 million |
| Nebraska | 31 | $25.8 million |
| Utah | 14 | $21.0 million |
| New Jersey | 31 | $19.5 million |
| Wisconsin | 15 | $15.6 million |
| Alabama | 13 | $13.8 million |
| Oklahoma | 5 | $12.9 million |
| Iowa | 11 | $11.8 million |
| Kansas | 12 | $10.9 million |
| Arizona | 12 | $9.7 million |
| District of Columbia | 11 | $5.2 million |
| Arkansas | 5 | $4.3 million |
| Mississippi | 4 | $2.6 million |
| New Hampshire | 4 | $2.2 million |
| South Dakota | 3 | $1.9 million |
| West Virginia | 2 | $1.7 million |
| North Dakota | 3 | $1.5 million |
| Puerto Rico | 1 | $1.4 million |
| Delaware | 1 | $1.2 million |
| Vermont | 2 | $416,558 |
| Alaska | 2 | $308,146 |
| Nevada | 1 | $150,526 |
| Maine | 1 | $91,407 |
| Montana | 1 | $6,967 |